B45.2 Cutaneous cryptococcosis

Name of the Condition

• Cutaneous Cryptococcosis

Summary

Cutaneous cryptococcosis is a fungal infection of the skin caused by the Cryptococcus species, most commonly Cryptococcus neoformans. It occurs when the fungus disseminates from a primary site (often the lungs) to the skin, resulting in localized or generalized skin lesions. The condition is typically opportunistic, affecting individuals with weakened immune systems, and may present with a range of skin manifestations depending on the extent of infection and host immunity.

Causes

The infection results from the spread of Cryptococcus organisms from a primary site (usually the lungs) to the skin. This dissemination occurs when the fungus enters the bloodstream and reaches the skin, often in individuals with compromised immune function. The fungus is commonly found in soil contaminated with bird droppings, and inhalation of spores is the initial route of infection.

Risk Factors

• Weakened immune system, such as from HIV/AIDS, organ transplantation, or immunosuppressive therapy.
• Chronic conditions that impair immunity, including diabetes or cancer.
• Exposure to environments with high concentrations of Cryptococcus spores, such as areas with bird droppings.
• Disseminated cryptococcosis from a primary infection site (e.g., lungs or central nervous system).

Symptoms

• Skin lesions, which may appear as papules, nodules, ulcers, or plaques.
• Lesions may be painless or mildly tender.
• Lesions can be localized or widespread, depending on the extent of dissemination.
• In some cases, lesions may resemble other skin conditions, such as molluscum contagiosum or abscesses.

Diagnosis

Diagnosis involves clinical evaluation of skin lesions, followed by laboratory testing. A skin biopsy may be performed to identify Cryptococcus organisms, often using special stains or cultures. Blood or cerebrospinal fluid tests may also be conducted to assess for systemic infection, especially if dissemination is suspected. Imaging studies are not typically required for isolated cutaneous cases but may be used to evaluate for underlying or disseminated disease.

Treatment Options

Treatment focuses on antifungal therapy, with the choice of medication and duration depending on the severity of infection and immune status. Commonly used antifungals include fluconazole, amphotericin B, or itraconazole. In cases of severe or disseminated disease, combination therapy or longer treatment courses may be necessary. Supportive care, such as wound management for ulcerated lesions, may also be provided.

Prognosis and Follow-Up

Prognosis depends on the underlying immune status and the extent of infection. In immunocompetent individuals, cutaneous cryptococcosis often responds well to treatment, with lesions resolving over time. In immunocompromised patients, recurrence or progression to more severe disease (e.g., meningitis) is possible, requiring close monitoring. Follow-up may include repeat skin exams, laboratory tests, and imaging to ensure resolution and detect any systemic involvement.

Complications

• Dissemination to other organs, particularly the lungs or central nervous system.
• Secondary bacterial infections of skin lesions.
• Scarring or permanent skin changes after lesion resolution.
• Worsening of underlying immune conditions due to the infection.

Lifestyle & Prevention

• Avoid exposure to environments with high concentrations of bird droppings, such as pigeon roosts.
• Maintain good hygiene and skin care to reduce the risk of secondary infections.
• For immunocompromised individuals, follow medical advice to manage underlying conditions and reduce infection risk.
• Prompt treatment of primary infections (e.g., pulmonary cryptococcosis) can help prevent skin dissemination.

When to Seek Professional Help

Seek medical attention if skin lesions appear, especially with a history of immunosuppression or known fungal exposure. Immediate care is recommended if lesions are painful, rapidly spreading, or accompanied by systemic symptoms (e.g., fever, headache, or confusion), as these may indicate dissemination to other organs.

Tips for Medical Coders

When coding for cutaneous cryptococcosis, use ICD-10-CM code B45.2. Ensure documentation supports the diagnosis, including clinical findings (e.g., skin lesion description) and any relevant history (e.g., immunosuppression or prior fungal infection). If the condition is secondary to a more extensive infection (e.g., disseminated cryptococcosis), code the underlying condition first, followed by B45.2 for the cutaneous manifestation. Verify that the code aligns with the specific site and nature of the skin involvement as documented.